Key facts
- This page summarizes Tyler Blok's Form 4 filing for CytoDyn Inc. (CYDY).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2024, 21:01.
Tyler Blok - 03 Jan 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)
- Reporting relationship
- EVP of Legal Affairs
- Issuer ticker
- CYDY
- Reported as of
- 03 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2024, 21:01:14 UTC
- Prior SEC filing
- 25 Aug 2023
- Next SEC filing
- 30 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler Blok
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tyler Blok filed Form 4 for CytoDyn Inc. (CYDY) on 05 Jan 2024.
Change
- Previous filing in this sequence was filed on 25 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYDY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250
- Date
- 03 Jan 2024
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -100,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.6700
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +100,000
- Change %
- Price
- Shares after
- 100,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.2100
- Footnotes
- F2, F3
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,000,000
- Change %
- Price
- $0.000000
- Shares after
- 1,000,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- $0.2100
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026.
Footnote F2
The outstanding option was cancelled in exchange for a new option having a lower exercise price.
Footnote F3
35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026.
Footnote F4
145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027.